Global Sofosbuvir (CAS 1190307-88-0) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Sofosbuvir (CAS 1190307-88-0) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Sofosbuvir (CAS 1190307-88-0) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults Patients accounting for % of the Sofosbuvir (CAS 1190307-88-0) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity ≥ 98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sofosbuvir (CAS 1190307-88-0) include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, and Tecoland, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sofosbuvir (CAS 1190307-88-0) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity ≥ 98%
Purity ＜ 98%
Market segment by Application can be divided into
Adults Patients
Elderly Patients
The key market players for global Sofosbuvir (CAS 1190307-88-0) market are listed below:
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co., Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sofosbuvir (CAS 1190307-88-0) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sofosbuvir (CAS 1190307-88-0), with price, sales, revenue and global market share of Sofosbuvir (CAS 1190307-88-0) from 2019 to 2022.
Chapter 3, the Sofosbuvir (CAS 1190307-88-0) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sofosbuvir (CAS 1190307-88-0) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sofosbuvir (CAS 1190307-88-0) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sofosbuvir (CAS 1190307-88-0).
Chapter 13, 14, and 15, to describe Sofosbuvir (CAS 1190307-88-0) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Sofosbuvir (CAS 1190307-88-0) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Purity ≥ 98%
1.2.3 Purity ＜ 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults Patients
1.3.3 Elderly Patients
1.4 Global Sofosbuvir (CAS 1190307-88-0) Market Size & Forecast
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume (2017-2028)
1.4.3 Global Sofosbuvir (CAS 1190307-88-0) Price (2017-2028)
1.5 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity Analysis
1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Total Production Capacity (2017-2028)
1.5.2 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sofosbuvir (CAS 1190307-88-0) Market Drivers
1.6.2 Sofosbuvir (CAS 1190307-88-0) Market Restraints
1.6.3 Sofosbuvir (CAS 1190307-88-0) Trends Analysis
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business
2.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
2.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 DONG BANG FUTURE TECH & LIFE CO., LTD
2.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Details
2.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Major Business
2.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product and Services
2.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Beaukev Pharma International Pvt.Ltd
2.3.1 Beaukev Pharma International Pvt.Ltd Details
2.3.2 Beaukev Pharma International Pvt.Ltd Major Business
2.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
2.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 DEAFARMA
2.4.1 DEAFARMA Details
2.4.2 DEAFARMA Major Business
2.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Services
2.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tecoland
2.5.1 Tecoland Details
2.5.2 Tecoland Major Business
2.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Services
2.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Anhui HaiKang Pharmaceutical Co. Ltd
2.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Details
2.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Major Business
2.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
2.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai Haoyuan Chemexpress Co., Ltd
2.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Details
2.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Major Business
2.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
2.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Beijing Kawin Technology Share-holding Co
2.8.1 Beijing Kawin Technology Share-holding Co Details
2.8.2 Beijing Kawin Technology Share-holding Co Major Business
2.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Services
2.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hangzhou Longshine Bio-Tech Co
2.9.1 Hangzhou Longshine Bio-Tech Co Details
2.9.2 Hangzhou Longshine Bio-Tech Co Major Business
2.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Services
2.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sofosbuvir (CAS 1190307-88-0) Breakdown Data by Manufacturer
3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sofosbuvir (CAS 1190307-88-0)
3.4 Market Concentration Rate
3.4.1 Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share in 2021
3.4.2 Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share in 2021
3.5 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sofosbuvir (CAS 1190307-88-0) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Region
4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Region (2017-2028)
4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2028)
4.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028)
4.3 Europe Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028)
4.4 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028)
4.5 South America Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028)
4.6 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Type (2017-2028)
5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2028)
5.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Application (2017-2028)
6.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2028)
6.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)
7.2 North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)
7.3 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Country
7.3.1 North America Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2017-2028)
7.3.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)
8.2 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)
8.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Country
8.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2017-2028)
8.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)
9.2 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)
9.3 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Market Size by Region
9.3.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)
10.2 South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)
10.3 South America Sofosbuvir (CAS 1190307-88-0) Market Size by Country
10.3.1 South America Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2017-2028)
10.3.2 South America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)
11.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)
11.3 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Country
11.3.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sofosbuvir (CAS 1190307-88-0) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sofosbuvir (CAS 1190307-88-0)
12.3 Sofosbuvir (CAS 1190307-88-0) Production Process
12.4 Sofosbuvir (CAS 1190307-88-0) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sofosbuvir (CAS 1190307-88-0) Typical Distributors
13.3 Sofosbuvir (CAS 1190307-88-0) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceutical Industries Ltd Major Business
Table 5. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 6. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. DONG BANG FUTURE TECH & LIFE CO., LTD Basic Information, Manufacturing Base and Competitors
Table 8. DONG BANG FUTURE TECH & LIFE CO., LTD Major Business
Table 9. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 10. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Beaukev Pharma International Pvt.Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Beaukev Pharma International Pvt.Ltd Major Business
Table 13. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 14. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. DEAFARMA Basic Information, Manufacturing Base and Competitors
Table 16. DEAFARMA Major Business
Table 17. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 18. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Tecoland Basic Information, Manufacturing Base and Competitors
Table 20. Tecoland Major Business
Table 21. Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 22. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Anhui HaiKang Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Anhui HaiKang Pharmaceutical Co. Ltd Major Business
Table 25. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 26. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shanghai Haoyuan Chemexpress Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai Haoyuan Chemexpress Co., Ltd Major Business
Table 29. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 30. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Beijing Kawin Technology Share-holding Co Basic Information, Manufacturing Base and Competitors
Table 32. Beijing Kawin Technology Share-holding Co Major Business
Table 33. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 34. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Hangzhou Longshine Bio-Tech Co Basic Information, Manufacturing Base and Competitors
Table 36. Hangzhou Longshine Bio-Tech Co Major Business
Table 37. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 38. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 40. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Sofosbuvir (CAS 1190307-88-0), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Company, (MT): 2020 VS 2021
Table 43. Head Office and Sofosbuvir (CAS 1190307-88-0) Production Site of Key Manufacturer
Table 44. Sofosbuvir (CAS 1190307-88-0) New Entrant and Capacity Expansion Plans
Table 45. Sofosbuvir (CAS 1190307-88-0) Mergers & Acquisitions in the Past Five Years
Table 46. Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022) & (MT)
Table 47. Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2023-2028) & (MT)
Table 48. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 51. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)
Table 52. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2017-2022) & (USD/MT)
Table 55. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2023-2028) & (USD/MT)
Table 56. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 57. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)
Table 58. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2017-2022) & (USD/MT)
Table 61. Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2023-2028) & (USD/MT)
Table 62. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)
Table 63. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)
Table 64. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 67. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)
Table 68. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 69. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)
Table 70. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)
Table 71. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)
Table 72. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 75. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)
Table 76. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 77. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)
Table 78. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022) & (MT)
Table 79. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2023-2028) & (MT)
Table 80. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 83. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)
Table 84. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 85. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)
Table 86. South America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)
Table 87. South America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)
Table 88. South America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 91. South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)
Table 92. South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 93. South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)
Table 94. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022) & (MT)
Table 95. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Region (2023-2028) & (MT)
Table 96. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)
Table 99. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)
Table 100. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)
Table 101. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)
Table 102. Sofosbuvir (CAS 1190307-88-0) Raw Material
Table 103. Key Manufacturers of Sofosbuvir (CAS 1190307-88-0) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Sofosbuvir (CAS 1190307-88-0) Typical Distributors
Table 107. Sofosbuvir (CAS 1190307-88-0) Typical Customers
List of Figures
Figure 1. Sofosbuvir (CAS 1190307-88-0) Picture
Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type in 2021
Figure 3. Purity ≥ 98%
Figure 4. Purity ＜ 98%
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application in 2021
Figure 6. Adults Patients
Figure 7. Elderly Patients
Figure 8. Global Sofosbuvir (CAS 1190307-88-0) Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Sales (2017-2028) & (MT)
Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Price (2017-2028) & (USD/MT)
Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (2017-2028) & (MT)
Figure 13. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Sofosbuvir (CAS 1190307-88-0) Market Drivers
Figure 15. Sofosbuvir (CAS 1190307-88-0) Market Restraints
Figure 16. Sofosbuvir (CAS 1190307-88-0) Market Trends
Figure 17. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturer in 2021
Figure 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2021
Figure 19. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2028)
Figure 23. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2017-2028)
Figure 24. North America Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (USD Million)
Figure 25. Europe Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (USD Million)
Figure 27. South America Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (USD Million)
Figure 29. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)
Figure 30. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)
Figure 31. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2017-2028) & (USD/MT)
Figure 32. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)
Figure 33. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)
Figure 34. Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2017-2028) & (USD/MT)
Figure 35. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)
Figure 36. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)
Figure 37. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2017-2028)
Figure 38. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2017-2028)
Figure 39. United States Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)
Figure 43. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)
Figure 44. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2017-2028)
Figure 45. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2017-2028)
Figure 46. Germany Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2017-2028)
Figure 55. China Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)
Figure 62. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)
Figure 63. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2017-2028)
Figure 64. South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Sofosbuvir (CAS 1190307-88-0) in 2021
Figure 76. Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
Figure 77. Sofosbuvir (CAS 1190307-88-0) Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
